SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 78.87-1.3%Dec 2 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Saulamanca who wrote (547)3/5/2004 12:55:51 PM
From: Jibacoa   of 3722
 
INGN Well,lately it seems that we can expect it. Whenever a stock seems poised for a possible up-move, they decide to offer some stock at a lower price so that "private investors" can take advantage of it,( of course, after first shorting the stock <g>)

The stock opened on a downgap and is presently testing support at yesterday's L of 9 (I think I will wait and see if I can pick-up some at $8.50 <g>)

bigcharts.marketwatch.com

Introgen Therapeutics, Inc. Announces Proposed Common Stock Offering
Friday March 5, 8:13 am ET

AUSTIN, Texas, March 5 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN - News) today announced plans to offer 5.5 million shares of common stock in an underwritten public offering under its existing shelf registration statement. The underwriters will have an option to purchase an additional 825,000 shares to cover over-allotments, if any.
UBS Securities LLC is acting as the sole book-running manager in this offering. SG Cowen and Leerink Swann and Company are acting as co-managers.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities. This offering of shares of common stock may be made only by means of a prospectus supplement and accompanying prospectus. Copies of the prospectus supplement and the accompanying prospectus can be obtained from UBS Securities LLC, 299 Park Avenue, New York, NY 10171.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext